Meta-Analysis of Gastrointestinal Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
Mohanavelu P, Mutnick M, Mehra N, White B, Kudrimoti S, Hernandez Kluesner K, Chen X, Nguyen T, Horlander E, Thenot H, Kota V, Mitchell CS.
Mohanavelu P, et al. Among authors: kota v.
Cancers (Basel). 2021 Apr 1;13(7):1643. doi: 10.3390/cancers13071643.
Cancers (Basel). 2021.
PMID: 33915952
Free PMC article.